arrow
Back
M

Matthew I. Milowsky

school of medicine

66H-index
575Paper Count
1.8WCitation Count
Published Papers 141
Publication Date
Online support needs and preferences for survivors of testicular cancer: a qualitative descriptive study
err2026-08-07
err0
PREAI
errSonam J. Shah; Samuel Tate; Mary W. Dunn; Matthew I. Milowsky; Allison J. Lazard; Lixin Song; Deborah Usinger; Maihan B. Vu; Matt Cross; Rich DeSelm; Adrian Gerstel; Hung-Jui Tan
errShare
errSave
A small-molecule inverse agonist of PPARγ for advanced solid tumors: a phase 1 trial
err2026-02-01
err0
errOAAI
errGalsky, Matthew D.; Mantia, Charlene; Bowden, Michaela; Bellmunt, Joaquim; Garmezy, Benjamin; Iyer, Gopa; Petrylak, Daniel P.; Rasco, Drew; Gupta, Shilpa; Rodriguez-Rivera, Ildefonso; Mikhailov, Yelena; Joshi, Adarsh; Nguyen, Phuong A.; Kakrecha, Bijal; Tepper, Jennifer; Costa, Anne Marie; McCrone, Carolyn; Rossi, Alex P.; Mertz, Jennifer A.; Gjini, Evisa; Meyers, Michael L.; Milowsky, Matthew I.; Gao, Xin
errShare
errSave
APOBEC3 promotes squamous differentiation via IL-1A/AP-1 signaling
err2025-12-14
err0
errOAAI
errMichael S. Sturdivant; Andrew S. Truong; Mi Zhou; Elliott D. Toomer; Wolfgang Beckabir; John Raupp; Ujjawal Manocha; Ibardo A. Zambrano; Hung-Jui Tan; Marc A. Bjurlin; Angela B. Smith; Tracy L. Rose; Matthew I. Milowsky; Sara E. Wobker; Kathryn H. Gessner; Jeffrey S. Damrauer; William Y. Kim
errShare
errSave
Advanced Urologic Cancer Consensus Conference (AUC3) 2025: Expert consensus on the management of renal cell and urinary tract cancers
err2025-12-13
err0
errOAAI
errRana R. McKay MD; Sumanta Pal MD; Wanling Xie MS; David Aggen MD, PhD; Laurence Albiges MD, PhD; Andrea Apolo MD; Michael B. Atkins MD; Rick Bangs MBA, PMP; Kathryn E. Beckermann MD, PhD; Joaquim Bellmunt MD, PhD; Stephanie A. Berg DO; Mehmet A. Bilen MD; David Braun MD, PhD; Maria I. Carlo MD; Jason Efstathiou MD, DPhil; Matthew Galsky MD; Petros Grivas MD, PhD; Shilpa Gupta MD; Naomi Haas MD; A. Ari Hakimi MD; Hans Hammers MD, PhD; Daniel Y. C. Heng MSC; Michelle Hirsch MD, PhD; Gopakumar Iyer MD; Eric Jonasch MD; Vadim S. Koshkin MD; Oleksandr Kryvenko MD; Bryan Lewis JD; Roger Li MD; Surena Matin MD; Benjamin Maughan MD, PharmD; David F. McDermott MD; Bradley McGregor MD; Joshua Meeks MD, PhD; Matthew Milowsky MD; Robert Motzer MD; Andrea Necchi MD; Dan Petrylak MD; Sima Porten MD, MPH; Thomas Powles MBBS, MRCP, MD; Brian Rini MD; Brian Shuch MD; Arlene Siefker-Radtke MD; Guru Sonpavde MD; S. Srikala Sridhar MD; Cristina Suarez MD, PhD; Chad Tang MD; Abhishek Tripathi MD; Michiel S. Van Der Heijden MD, PhD; Martin Voss MD; Wenxin Xu MD; Tian Zhang MD; Jonathan Rosenberg MD; Toni K. Choueiri MD
errShare
errSave
Efficacy of erdafitinib before or after enfortumab vedotin in FGFR3-altered advanced urothelial cancer: analysis of the UNITE collaborative study
err2025-11-01
err0
PREAI
errJiang, Cindy Y.; Hwang, Hyunsoo; Epstein, Ilana Y.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Taylor, Amy K.; Nizam, Amanda; Jindal, Tanya; Glover, Michael J.; Khaki, Ali Raza; Barata, Pedro C.; Nguyen, Charles B.; Oh, Eugene; Davis, Nancy B.; Mabey, Hannah; Hoimes, Christopher J.; Evans, Sean T.; Abuqayas, Bashar; Lemke, Emily; Tsung, Irene; Qiao, Wei; Kilari, Deepak; Zakharia, Yousef; Bilen, Mehmet A.; Milowsky, Matthew, I; Shah, Sumit A.; Gupta, Shilpa; Emamekhoo, Hamid; Bellmunt, Joaquim; Alva, Ajjai S.; Grivas, Petros; Msaouel, Pavlos; Koshkin, Vadim S.; Campbell, Matthew T.; Alhalabi, Omar
errShare
errSave
Adjuvant nivolumab versus placebo for high-risk muscle-invasive urothelial carcinoma: 5-year efficacy and ctDNA results from CheckMate 274
err2025-10-17
err0
errOAAI
errM.D. Galsky; J.E. Gschwend; M.I. Milowsky; M. Schenker; B.P. Valderrama; Y. Tomita; A. Bamias; T. Lebret; S.F. Shariat; S.H. Park; M. Agerbaek; G. Jha; F. Stenner; D. Ye; F. Giudici; J. Connors; S. Gupta; A. Chhibber; J. Zhang; D.F. Bajorin; J.A. Witjes
errShare
errSave
Treatment-Related Adverse Events and Associated Outcomes in Patients With Advanced Urothelial Carcinoma Treated With Enfortumab Vedotin: Analysis of the UNITE Study
err2025-10-02
err0
errOAAI
errNizam, Amanda; Nguyen, Charles B.; Li, Jinju; Zabor, Emily C.; Msaouel, Pavlos; Jiang, Cindy Y.; Alhalabi, Omar; Oh, Eugene; Davidsohn, Matthew P.; Epstein, Ilana B.; Bakaloudi, Dimitra Rafailia; Talukder, Rafee; Jindal, Tanya; Taylor, Amy K.; Glover, Michael J.; Khaki, Ali Raza; Lemke, Emily; Mabey, Hannah; Abuqayas, Bashar; Jang, Albert; Brown, Jason R.; Evans, Sean T.; Pywell, Cameron; Basu, Arnab; Bilen, Mehmet A.; Barata, Pedro C.; Zakharia, Yousef; Milowsky, Matthew I.; Kilari, Deepak; Hoimes, Christopher J.; Shah, Sumit A.; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Grivas, Petros; Bellmunt, Joaquim; Campbell, Matthew T.; Alva, Ajjai S.; Koshkin, Vadim S.
errShare
errSave
Outcomes with Enfortumab Vedotin in Patients with Histologic Subtypes of Advanced Urothelial Carcinoma: Analysis of the UNITE Study
err2025-09-14
err0
PREAI
errTanya Jindal; Cindy Y. Jiang; Omar Alhalabi; Charles B. Nguyen; Eugene Oh; Irene Tsung; Dimitra Rafailia Bakaloudi; Rafee Talukder; Matthew Davidsohn; Dory Freeman; Ilana Y. Epstein; Chien-Kuang Cornelia Ding; Amanda Nizam; Michael J. Glover; Ali Raza Khaki; Amy K. Taylor; Emily Lemke; Albert Jang; Sean T. Evans; Denny Shin; Cameron Pywell; Arnab Basu; Mehmet A. Bilen; Yousef Zakharia; Pedro Barata; Matthew I. Milowsky; Jason Brown; Deepak Kilari; Hamid Emamekhoo; Christopher J. Hoimes; Sumit Shah; Nancy B. Davis; Shilpa Gupta; Petros Grivas; Joaquim Bellmunt; Ajjai Alva; Matthew T. Campbell; Vadim S. Koshkin
errShare
errSave
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial
err2025-08-07
err0
PREAI
errMatthew D. Galsky; Dean F. Bajorin; Yoshihiko Tomita; Dingwei Ye; Mads Agerbaek; Deborah Enting; Avivit Peer; Matthew Milowsky; Ko Kobayashi; Marc-Oliver Grimm; Frank Stenner; Justin M. David; Jun Li; Scott D. Chasalow; Federico Nasroulah; Abraham Apfel; Keziban Ünsal-Kaçmaz; Andrea Necchi
errShare
errSave
A Systematic Review and Meta-analysis on Perioperative Stenting/Dwell Time and Postoperative Outcomes in Patients Undergoing Radical Cystectomy and Urinary Diversion for Bladder Cancer
err2025-06-01
err0
errOAAI
errMithun Kailavasan; Alberto Martini; Max Bruins; Albert Carrion; Richard Cathomas; Eva Compérat; Jason A. Efstathiou; Rainer Fietkau; Anna Lorch; Laura S. Mertens; Richard P. Meijer; Paramananthan Mariappan; Mathew I. Milowsky; Yann Neuzillet; Valeria Panebianco; Michael Rink; George N. Thalmann; S. Sæbjørnsen; Antoine G. van der Heijden
errShare
errSave
Mechanistic Insights and Future Directions for Enfortumab Vedotin in Urothelial Carcinoma: Highlights from the 10th Annual Leo & Anne Albert Institute for Bladder Cancer Care and Research Symposium
err2025-05-14
err0
errOAAI
errFahey, Catherine C.; Clark-Garvey, Sean; Porten, Sima; Kamat, Ashish M.; Flaig, Thomas W.; Taylor, John A.; Kim, William Y.; Milowsky, Matthew I.
errShare
errSave
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2025 Guidelines
err2025-05-01
err0
PREAI
errvan der Heijden, Antoine G.; Bruins, Harman Max; Carrion, Albert; Cathomas, Richard; Comperat, Eva; Dimitropoulos, Konstantinos; Efstathiou, Jason A.; Fietkau, Rainer; Kailavasan, Mithun; Lorch, Anja; Martini, Alberto; Mertens, Laura S.; Meijer, Richard P.; Mariappan, Param; Milowsky, Matthew I.; Neuzillet, Yann; Panebianco, Valeria; Sabjornsen, Sabjorn; Smith, Emma J.; Thalmann, George N.; Rink, Michael
errShare
errSave
Genomic Biomarkers Associated with Enfortumab Vedotin Outcomes for Patients with Advanced Urothelial Carcinoma: Analysis of UNITE Study Data
err2024-12-01
err1
errOAAI
errJindal, Tanya; Jiang, Cindy; Alhalabi, Omar; Nizam, Amanda; Nguyen, Charles; Talukder, Rafee; Bakaloudi, Dimitra; Davidsohn, Matthew; Freeman, Dory; Glover, Michael; Khaki, Ali Raza; Evans, Sean; Lemke, Emily; Bose, Rohit; Sim, Woogwang; Pywell, Cameron; Basu, Arnab; Kilari, Deepak; Barata, Pedro C.; Bilen, Mehmet A.; Zakharia, Yousef; Milowsky, Matthew I.; Shah, Sumit A.; Bellmunt, Joaquim; Grivas, Petros; Emamekhoo, Hamid; Davis, Nancy B.; Gupta, Shilpa; Hoimes, Christopher; Campbell, Matthew T.; Alva, Ajjai; Koshkin, Vadim S.
errShare
errSave
Pre-treatment (Tx) risk factors for enfortumab vedotin-induced peripheral neuropathy (EVIPN) in patients (pts) with advanced urothelial carcinoma (aUC): Analysis of UNITE
err2024-09-01
err0
PREAI
errNizam, A.; Zhang, L.; Jiang, C. Y.; Nguyen, C. B.; Bakaloudi, D. R.; Bilen, M. A.; Barata, P. M. Coelho; Zakharia, Y.; Milowsky, M. I.; Kilari, D.; Hoimes, C. J.; Khaki, A. R.; Emamekhoo, H.; Gupta, S.; Grivas, P.; Bellmunt, J.; Alva, A. S.; Campbell, M. T.; Alhalabi, O.; Koshkin, V. S.
errShare
errSave
Efficacy of enfortumab vedotin (EV) in patients (pts) with (w) advanced urothelial carcinoma (aUC) who have baseline neuropathy (N) and/or diabetes mellitus (DM): A UNITE study analysis
err2024-09-01
err0
PREAI
errJang, A.; Jindal, T.; Jiang, C. Y.; Nguyen, C. B.; Nizam, A.; Alva, A. S.; Grivas, P.; Bellmunt, J.; Hoimes, C. J.; Bilen, M. A.; Emamekhoo, H.; Milowsky, M. I.; Khaki, A. R.; Gupta, S.; Campbell, M. T.; Alhalabi, O.; Chen, Z.; Fu, P.; Koshkin, V. S.; Brown, J. R.
errShare
errSave
Enfortumab vedotin (EV) plus pembrolizumab (P) outcomes outside clinical trials and biomarkers of benefit in patients (pts) with advanced urothelial carcinoma: Analysis of the UNITE study
err2024-09-01
err0
PREAI
errJindal, T.; Jiang, C. Y.; Alhalabi, O.; Tsung, I.; Jang, A.; Bakaloudi, D. R.; Sidhom, F.; Taylor, A. K.; Hoimes, C. J.; Bellmunt, J.; Bilen, M. A.; Gupta, S.; Milowsky, M. I.; Shah, S.; Basu, A.; Grivas, P.; Brown, J. R.; Campbell, M. T.; Alva, A. S.; Koshkin, V. S.
errShare
errSave
Study EV-103 dose escalation/cohort A (DE/A): 5y follow-up of first-line (1L) enfortumab vedotin (EV) plus pembrolizumab (P) in cisplatin (CIS)-ineligible locally advanced or metastatic urothelial carcinoma (la/mUC)
err2024-09-01
err2
PREAI
errRosenberg, J. E.; Petrylak, D. P.; Flaig, T.; Hoimes, C. J.; Gupta, S.; O'Donnell, P. H.; Mar, N.; Friedlander, T.; Tagawa, S. T.; Bilen, M. A.; Brown, J. R.; McKay, R. R.; Merchan, J. R.; Srinivas, S.; Shetty, A.; Homet Moreno, B.; Davis, G.; Wirtz, H.; Zhu, Y.; Milowsky, M. I.
errShare
errSave
PD-L1 expression and correlation with outcome in muscle-invasive and metastatic urothelial carcinoma: review and critical discussion
err2024-08-30
err0
errOAAI
errEl Saadany, Taemer; Lorch, Anja; Milowsky, Matthew I.; Vogl, Ursula Maria; Cathomas, Richard
errShare
errSave
Decisional Conflict Among Patients Newly Diagnosed With Clinical T1 Renal Masses: A Prospective Study
err2024-08-01
err1
PREAI
errFeinberg, Amir; Gessner, Kathryn H.; Deal, Allison M.; Heiling, Hillary M.; Myers, Shannon; Raynor, Mathew C.; Milowsky, Matthew I.; Wobker, Sara E.; Commander, Clayton W.; Lazard, Allison J.; Bjurlin, Marc A.; Smith, Angela B.; Johnson, David C.; Wallen, Eric M.; Kim, William Y.; Tan, Hung-Jui
errShare
errSave